Eledon Pharmaceuticals (FRA:2TK) Beginning Cash Position : €5.25 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eledon Pharmaceuticals Beginning Cash Position?

Eledon Pharmaceuticals's Beginning Cash Position for the quarter that ended in Jun. 2024 was €5.25 Mil.

Eledon Pharmaceuticals's quarterly Beginning Cash Position increased from Dec. 2023 (€3.36 Mil) to Mar. 2024 (€4.24 Mil) and increased from Mar. 2024 (€4.24 Mil) to Jun. 2024 (€5.25 Mil).

Eledon Pharmaceuticals's annual Beginning Cash Position declined from Dec. 2021 (€101.06 Mil) to Dec. 2022 (€80.08 Mil) and declined from Dec. 2022 (€80.08 Mil) to Dec. 2023 (€51.73 Mil).

Eledon Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Eledon Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eledon Pharmaceuticals Beginning Cash Position Chart

Eledon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

11.68

7.23

101.06

80.08

51.73

Eledon Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															42.91	38.37	3.36	4.24	5.25

Eledon Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Eledon Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Eledon Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Eledon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eledon Pharmaceuticals Inc (FRA:2TK) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ELDN:USA

Address

19900 MacArthur Boulevard, Suite 550, Irvine, CA, USA, 92612

Website

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

Eledon Pharmaceuticals Headlines

No Headlines